Who Owns Harvard Bioscience Stock?
NASDAQ: HBIOIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 42.01%
- Held by insiders
- 9.39%
- Institutional holders
- 47
- Institutions 42.0%
- Insiders 9.4%
- Public and other 48.6%
Who owns Harvard Bioscience stock?
Institutional investors own about 42.0% of Harvard Bioscience's shares, spread across 47 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 9.39% of HBIO.
The largest institutional holders are Weber Capital Management LLC /ADV (6.83%), Meros Investment Management, Lp (4.02%) and Acadian Asset Management. LLC (3.95%). Together, the top 10 institutions control 31.5% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their HBIO positions and 5 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of HBIO
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Weber Capital Management LLC /ADV | 310.86K | 6.83% | -2.9% |
| Meros Investment Management, Lp | 182.99K | 4.02% | +54.4% |
| Acadian Asset Management. LLC | 179.61K | 3.95% | 0.0% |
| Vanguard Capital Management LLC | 169.63K | 3.73% | +3.9% |
| Nano Cap New Millennium Growth Fund L P | 143.08K | 3.14% | +21.8% |
| Corsair Capital Management, L.P. | 122.81K | 2.70% | -1.6% |
| Two Sigma Investments, LP | 114.55K | 2.52% | +0.4% |
| Renaissance Technologies, LLC | 99.33K | 2.18% | -2.1% |
| Blackrock Inc. | 61.83K | 1.36% | -0.6% |
| Geode Capital Management, LLC | 47.55K | 1.04% | -20.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of HBIO
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 123.47K | 2.71% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 42.04K | 0.92% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 22.39K | 0.49% |
| FORUM FUNDS II-Acuitas US Microcap Fund | 13.38K | 0.29% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 7.02K | 0.15% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 5.95K | 0.13% |
| VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fund | 4.11K | 0.09% |
| GAMCO Global Series Funds, Inc-Gabelli Global Mini Mites Fund | 4.00K | 0.09% |
| Dimensional ETF Trust-Dimensional US Sustainability Core 1 ETF | 1.90K | 0.04% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 1.70K | 0.04% |
Frequently asked questions
Who is the largest shareholder of Harvard Bioscience?
Weber Capital Management LLC /ADV is the largest institutional shareholder of HBIO, owning 6.83% of shares outstanding (310.86K shares) as of its latest 13F filing.
What percentage of Harvard Bioscience is owned by institutions?
Institutions own about 42.0% of HBIO shares and 46.4% of the public float.
How much of Harvard Bioscience do insiders own?
Insiders, such as officers and directors, own about 9.39% of HBIO shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.